MANCINI, Stefania
 Distribuzione geografica
Continente #
NA - Nord America 1.196
EU - Europa 638
AS - Asia 216
AF - Africa 44
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 2.096
Nazione #
US - Stati Uniti d'America 1.194
IT - Italia 209
UA - Ucraina 118
SE - Svezia 71
CN - Cina 66
IE - Irlanda 64
SG - Singapore 54
DE - Germania 53
TR - Turchia 47
DK - Danimarca 46
FI - Finlandia 32
CI - Costa d'Avorio 28
KR - Corea 26
GB - Regno Unito 17
MA - Marocco 16
IN - India 14
FR - Francia 11
BE - Belgio 9
GR - Grecia 4
HK - Hong Kong 4
CA - Canada 2
IR - Iran 2
JP - Giappone 2
AT - Austria 1
CH - Svizzera 1
CZ - Repubblica Ceca 1
EU - Europa 1
NZ - Nuova Zelanda 1
PH - Filippine 1
PT - Portogallo 1
Totale 2.096
Città #
Chandler 170
Fairfield 120
Jacksonville 120
Ashburn 89
Boardman 66
Dublin 64
Wilmington 55
Houston 52
New York 52
Woodbridge 46
Seattle 45
Ann Arbor 43
Cambridge 33
Des Moines 31
Abidjan 28
Pianella 27
Lawrence 25
Princeton 25
San Mateo 25
Turin 25
Singapore 24
Beijing 23
Centro 23
Porto 22
Marche 9
Milan 9
San Diego 9
Los Angeles 8
Brussels 7
Helsinki 7
Cagliari 6
Hyderabad 6
Pune 6
Shanghai 6
Catania 5
Guangzhou 5
Redmond 5
Hong Kong 4
London 4
Wuhan 4
Wuxi 4
Civitanova Marche 3
Norwalk 3
Pistoia 3
Vercelli 3
Albiate 2
Ancona 2
Athens 2
Delhi 2
Markopoulo Mesogaias 2
Ningbo 2
Ottawa 2
Palermo 2
Prescot 2
Rome 2
Seoul 2
Storo 2
Terlizzi 2
Tolentino 2
Venice 2
Washington 2
Zibo 2
Acton 1
Agugliano 1
Auburn Hills 1
Casalecchio di Reno 1
Clifton 1
Dalian 1
Dallas 1
Fayetteville 1
Fermo 1
Fossombrone 1
Gaiole In Chianti 1
Glendale 1
Hebei 1
Hounslow 1
Istanbul 1
Izmir 1
Kagoya 1
Kilburn 1
Kish 1
Lausanne 1
Manila 1
Nürnberg 1
Olomouc 1
Pesaro 1
Pisa 1
Prineville 1
Reggio Calabria 1
Simi Valley 1
Southwark 1
Stockholm 1
Tauranga 1
Tokyo 1
Torre Del Greco 1
Tübingen 1
Vienna 1
Totale 1.418
Nome #
Serum Inflamma-miR Signature: A Biomarker of Myelodysplastic Syndrome? 152
Human de-differentiated adipocytes show similar properties to bone marrow derived mesenchymal stem cells 136
Conditioning regimen with beam plus amifostine for outpatient autologous stem cell tansplantation: feasibility and outcome in 97 lymphoma patients. 124
Glial-like differentiation potential of human mature adipocytes 108
Human bone marrow adipocytes maintain the survival and differentiation of hematopoietic stem cells 102
Azacitidine Treatment in High Risk Myelodysplastic Patients in Complete Haematological Remission Reverts Mesenchymal Stem Cells to a Normal Phenotype 101
Gene expression profile of cytokines in patients with chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation with reduced conditioning. 96
Plasticity of human dedifferentiated adipocytes toward endothelial cells 93
Biosafety evidence for human dedifferentiated adipocytes 89
Direct demonstration of cytokeratin filaments by electron microscopy in K562 cell lines in liquid culture 88
Long lasting biological effects of PDGFR agonistic auto-antibodies in scleroderma 88
Interaction between human mature adipocytes and lymphocytes induces T-cell proliferation 77
Overexpression of CDKN2B (p15INK4B) and altered global DNA methylation status in mesenchymal stem cells of high-risk myelodysplastic syndromes 76
DNA demethylating therapy reverts mesenchymal stromal cells derived from high risk myelodysplastic patients to a normal phenotype 75
LA POSITIVITÀ DEL WT1 POST-INDUZIONE È UN IMPORTANTE FATTORE PROGNOSTICO PREDITTIVO DI RECIDIVA PRECOCE IN UNA CASISTICA DI 80 PAZIENTI AFFETTI DA LEUCEMIA ACUTA MIELOIDE 70
DHAP regimen plus G-CSF as salvage therapy and priming for blood progenitor cell collection in patients with poor prognosis lymphoma. 67
Cytokine expression profile of selected cell populations from patients with chronic graft-versus-host disease after allogeneic bone marrow transplantation wih reduced conditioning. 66
Identification of different adypocytes populations within human marrow microenvironment 66
OVEREXPRESSION OF CDKN2B IS ASSOCIATED WITH REDUCED PROLIFERATIVE POTENTIAL IN MESENCHYMAL STEM CELL FROM HIGH-RISK MYELODYSPLASTIC SYNDROME 62
TREATMENT WITH AZACITIDINE REVERSES MESENCHYMAL STEM CELLS DERIVED FROM HIGH RISK MYELODYSPLASTIC PATIENTS TO A NORMAL PHENOTYPE 60
Predictive value of post-induction and post-consolidation MRD: a comparison of multiparameter flow cytometry and WT1 RT-PCR techniques in 75 acute myeloid leukemia (AML) patients 59
Mesenchymal stem cells of myelodysplastic syndromes show impaired hematopoietic support function and global DNA hypermethylation status 57
Factors affecting hemopoietic recovery after high-dose therapy and autologous peripheral blood progenitor cell transplantation: a single center experience. 56
Acute promyelocyte leukemia arose from CALR 1 mutated post essential thrombocythemia- myelofibrosis with splanchnic vein thrombosis: A case report 56
Ruolo degli adipociti nell’emopoiesi umana 51
Pharmacologic bone marrow purging: is there any place for etoposide? In vitro comparison with mafosfamide. 50
P1045: IS JAK2V617F BUT NOT CALR AS DRIVER MUTATION ENOUGH BY ITSELF IN THE PATHOGENESIS OF UNUSUAL TYPE VENOUS THROMBOSIS IN MPN PATIENTS? 23
A rare case of aCML associated with CNS involvement and with aggressive clinical course 22
Totale 2.170
Categoria #
all - tutte 10.333
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 10.333


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020140 0 0 0 0 26 0 27 2 24 3 26 32
2020/2021464 11 42 35 1 100 75 86 12 34 14 41 13
2021/2022217 12 50 5 12 2 7 6 15 16 28 16 48
2022/2023482 37 65 32 40 25 73 2 31 100 2 58 17
2023/2024301 41 7 16 31 38 85 9 20 2 14 12 26
2024/2025151 80 47 20 4 0 0 0 0 0 0 0 0
Totale 2.170